Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

Multi-Parameter Flow Cytometry(FC) Can Detect Proliferating Myeloma Cells After Treatment: Implications for Targeting the Myeloma Proliferative Component

John Lust, MD, PhD, Shaji Kumar, MD, Michael Timm, Kathleen Donovan, PhD, Philip R. Greipp, MD, William Morice, MD, PhD

Blood (2010) 116 (21): 4995.

https://doi.org/10.1182/blood.V116.21.4995.4995

Published: 2010

Journal Articles

Mechanisms of regulation of CXCR4/SDF-1 (CXCL12)–dependent migration and homing in multiple myeloma

Blood (2006) 109 (7): 2708–2717.

https://doi.org/10.1182/blood-2006-07-035857

Published: 2006

Journal Articles

Mi-63, a Small Molecule Inhibitor of MDM2-p53 Interaction, Has Significant In Vitro Activity in Multiple Myeloma.

Shaji Kumar, MD, Michael Timm, Michael P. Kline, Ph.D, Jessica L. Haug, Teresa K. Kimlinger, Dajun Yang, MD, S. Vincent Rajkumar, MD

Blood (2006) 108 (11): 3464.

https://doi.org/10.1182/blood.V108.11.3464.3464

Published: 2006

Journal Articles

Thymoglobulin (Polyclonal Rabbit Anti Thymocyte Globulin) Has In Vivo Activity in a Mouse Model of Myeloma.

Michael Timm, Linda Wellik, Teresa Kimlinger, Jessica Haug, Michael Kline, Ph.D, S. Vincent Rajkumar, MD, Philip Greipp, MD, Shaji Kumar, MD

Blood (2006) 108 (11): 3487.

https://doi.org/10.1182/blood.V108.11.3487.3487

Published: 2006

Journal Articles

Expression of CD126 (IL-R alpha) on Plasma Cells in Monoclonal Gammopathies.

Syed T. Mahmood, MD, Shaji Kumar, MD, Teresa K. Kimlinger, Jessica L. Haug, Michael Timm, Linda Wellik, Michael Kline, Ph.D, S. Vincent Rajkumar, MD

Blood (2006) 108 (11): 5066.

https://doi.org/10.1182/blood.V108.11.5066.5066

Published: 2006

Journal Articles

Proteomic Analysis of Post Transplant Lymphoproliferative Disorders (PTLD) Using Nanoscale Protein Microarray Techniques.

Yazan Alsayed, MD, Alexey Leontovich, PhD, Michael Timm, BS, Mona Melhem, MD, Michael Nalesnik, MD, Diane George, BS, Ujjal Singha, PhD, Alissa Huston, MD, Lanie Francis, MD, Suzanne Lentzsch, MD, G. David Roodman, MD, PhD, Ronald Herberman, MD, Irene M. Ghobrial, MD

Blood (2005) 106 (11): 286.

https://doi.org/10.1182/blood.V106.11.286.286

Published: 2005

Journal Articles

Combining Measurements of Plasma Cell Apoptosis and Proliferation in Multiple Myeloma Identifies Patients with Poor Survival.

Shaji Kumar, MD, Michael Timm, MD, Martha Q. Lacy, MD, Angela Dispenzieri, MD, Suzanne R. Hayman, MD, Morie A. Gertz, MD, S. Vincent Rajkumar, MD, Philip R. Greipp, MD, Thomas E. Witzig, MD

Blood (2005) 106 (11): 3410.

https://doi.org/10.1182/blood.V106.11.3410.3410

Published: 2005

Journal Articles

The Role of the CXCR4 Inhibitor AMD3100 in Multiple Myeloma (MM).

Irene M. Ghobrial, MD, Mona Melhem, Ujjal Singha, PhD, Diane George, PhD, Michael Timm, Lanie Francis, MD, Yazan Alsayed, MD, Alissa Huston, MD, G. D. Roodman, MD, PhD

Blood (2005) 106 (11): 2492.

https://doi.org/10.1182/blood.V106.11.2492.2492

Published: 2005

Journal Articles

Rapamycin Enhances the Cytotoxicity of Bortezomib and Rituximab on Mantle Cell Lymphoma (MCL) Cell Lines.

Laila K. Ismail, MD, Michael Timm, BS, Anne Novak, PhD, Mary Stenson, BS, Stephen M. Ansell, MD, PhD, Thomas E. Witzig, MD

Blood (2005) 106 (11): 2411.

https://doi.org/10.1182/blood.V106.11.2411.2411

Published: 2005

Journal Articles

The Effect of Rapamycin, 17-AAG and the Combination on the Bone Marrow Microenvironment in Multiple Myeloma (MM).

Lanie Francis, MD, Judy Anderson, BS, Michael Timm, BS, Noriyoshi Kurihara, PhD, Ujjal Singha, PhD, Yazan Alsayed, MD, Alissa Huston, MD, Suzanne Lentzsch, MD, PhD, G. David Roodman, MD, PhD, Irene M. Ghobrial, MD

Blood (2005) 106 (11): 3476.

https://doi.org/10.1182/blood.V106.11.3476.3476

Published: 2005

Journal Articles

Proteomic Analysis Identifies Differences in Multiple Myeloma (MM) Cells Sensitive and Resistant to AKT Inhibition.

Alissa Huston, MD, Alexey Leontovich, MD, Michael Timm, MD, Yazan Alsayed, MD, Ujjal Singha, PhD, Lanie Francis, MD, Ganwei Lu, PhD, Judy Anderson, Suzanne Lentzsch, MD, Irene Ghobrial, MD

Blood (2005) 106 (11): 3402.

https://doi.org/10.1182/blood.V106.11.3402.3402

Published: 2005

Journal Articles

AT-101, a Small Molecule Inhibitor of Bcl-2 Family Proteins, Has Significant In Vitro Activity in Multiple Myeloma.

Shaji Kumar, MD, Michael Kline, PhD, Terry Kimlinger, BA, Michael Timm, Jessica Haug, Philip R. Greipp, MD, Dajun Yang, MD, PhD, S. Vincent Rajkumar, MD

Blood (2005) 106 (11): 1581.

https://doi.org/10.1182/blood.V106.11.1581.1581

Published: 2005

Journal Articles

ABT-737, an Inhibitor of Bcl-2/Bcl-X L Proteins, Is Cytotoxic in Multiple Myeloma Cells.

Michael Kline, PhD, Terry Kimlinger, Michael Timm, Jessica Haug, John A. Lust, MD, PhD, S.Vincent Rajkumar, MD, Shaji Kumar

Blood (2005) 106 (11): 1589.

https://doi.org/10.1182/blood.V106.11.1589.1589

Published: 2005

Journal Articles

Proteomic Analysis of Waldenstrom Macroglobulinemia (WM) Using Nanoscale Protein Micorarray Techniques.

Yazan Alsayed, MD, Michael Timm, MD, Alexey Leontovich, MD, Daniel Santos, MD, Allen Ho, MD, Ujjal Singha, PhD, Lanie Francis, MD, Alissa Huston, MD, Ganwei Lu, MD, Suzanne Lentzsch, MD, G. David Roodman, MD, PhD, Leleu Xavier, MD, Steven Treon, MD, PhD, Irene M. Ghobrial, MD

Blood (2005) 106 (11): 504.

https://doi.org/10.1182/blood.V106.11.504.504

Published: 2005

Journal Articles

Thymoglobulin (Polyclonal Rabbit Anti Thymocyte Globulin) Has In Vitro Activity in Multiple Myeloma.

Shaji Kumar, MD, Michael Timm, Terry Kimlinger, Michael Kline, PhD, Jessica L. Haug, S. Vincent Rajkumar, MD, Philip R. Greipp, MD

Blood (2005) 106 (11): 5190.

https://doi.org/10.1182/blood.V106.11.5190.5190

Published: 2005

Journal Articles

Role of the Chemokine Receptor CXCR4 in Waldenstrom Macroglobulinemia.

Irene M. Ghobrial, MD, Mona Melhem, MD, Ujjal Singha, PhD, Diane George, Michael Timm, MD, Lanie Francis, MD, Yazan Alsayed, MD, Alissa Huston, MD, G. David Roodman, MD, PhD, Philip Greipp, MD, Morie Gertz, MD, Thomas Witzig, MD

Blood (2005) 106 (11): 993.

https://doi.org/10.1182/blood.V106.11.993.993

Published: 2005

Journal Articles

Proteomic Analysis of Multiple Myeloma Identifies Potential Targets for Drug Therapy.

Irene M. Ghobrial, MD, Jeanette E. Eckel, PhD, Alexey A. Leontovich, PhD, Michael Timm, BS, Gregory Ahmann, BS, Antje Hoering, PhD, Stephen Ziesmer, BS, Miguel Cabanela, MD, Alex Nehme, MD, Philip R. Greipp, MD, Rafael Fonseca, MD, Thomas E. Witzig, MD

Blood (2004) 104 (11): 2446.

https://doi.org/10.1182/blood.V104.11.2446.2446

Published: 2004

Journal Articles

Proteomic Analysis of Targeted Therapeutic Agents in Multiple Myeloma (MM).

Irene M. Ghobrial, MD, Jeanette E. Eckel, PhD, Antje Hoering, PhD, Michael Timm, BS, Alexey A. Leontovich, PhD, Rafael Fonseca, MD, Philip R. Greipp, MD, Thomas E. Witzig, MD

Blood (2004) 104 (11): 4299.

https://doi.org/10.1182/blood.V104.11.4299.4299

Published: 2004

Journal Articles

Proteomic Analysis of Waldenstrom Macroglobulinemia (WM) and IgM Monoclonal Gammopathy of Undetermined Significance (IgM-MGUS) Identifies Potential Targets for Drug Therapy.

Irene M. Ghobrial, MD, Alexey A. Leontocich, PhD, Jeanette E. Eckel, PhD, Michael Timm, BS, Steve Ziesmer, BS, Antje Hoering, PhD, Miguel Cabanela, MD, Alex Nehme, MD, Philip R. Greipp, MD, Rafael Fonseca, MD, Morie A. Gertz, MD, Thomas E. Witzig, MD

Blood (2004) 104 (11): 787.

https://doi.org/10.1182/blood.V104.11.787.787

Published: 2004

Journal Articles

Bone marrow angiogenic ability and expression of angiogenic cytokines in myeloma: evidence favoring loss of marrow angiogenesis inhibitory activity with disease progression

Shaji Kumar, Thomas E. Witzig, Michael Timm, Jessica Haug, Linda Wellik, Teresa K. Kimlinger, Philip R. Greipp, S. Vincent Rajkumar

Blood (2004) 104 (4): 1159–1165.

https://doi.org/10.1182/blood-2003-11-3811

Published: 2004

NARROW

Multi-Parameter Flow Cytometry(FC) Can Detect Proliferating Myeloma Cells After Treatment: Implications for Targeting the Myeloma Proliferative Component

Mechanisms of regulation of CXCR4/SDF-1 (CXCL12)–dependent migration and homing in multiple myeloma

Mi-63, a Small Molecule Inhibitor of MDM2-p53 Interaction, Has Significant In Vitro Activity in Multiple Myeloma.

Thymoglobulin (Polyclonal Rabbit Anti Thymocyte Globulin) Has In Vivo Activity in a Mouse Model of Myeloma.

Expression of CD126 (IL-R alpha) on Plasma Cells in Monoclonal Gammopathies.

Proteomic Analysis of Post Transplant Lymphoproliferative Disorders (PTLD) Using Nanoscale Protein Microarray Techniques.

Combining Measurements of Plasma Cell Apoptosis and Proliferation in Multiple Myeloma Identifies Patients with Poor Survival.

The Role of the CXCR4 Inhibitor AMD3100 in Multiple Myeloma (MM).

Rapamycin Enhances the Cytotoxicity of Bortezomib and Rituximab on Mantle Cell Lymphoma (MCL) Cell Lines.

The Effect of Rapamycin, 17-AAG and the Combination on the Bone Marrow Microenvironment in Multiple Myeloma (MM).

Proteomic Analysis Identifies Differences in Multiple Myeloma (MM) Cells Sensitive and Resistant to AKT Inhibition.

AT-101, a Small Molecule Inhibitor of Bcl-2 Family Proteins, Has Significant In Vitro Activity in Multiple Myeloma.

ABT-737, an Inhibitor of Bcl-2/Bcl-X L Proteins, Is Cytotoxic in Multiple Myeloma Cells.

Proteomic Analysis of Waldenstrom Macroglobulinemia (WM) Using Nanoscale Protein Micorarray Techniques.

Thymoglobulin (Polyclonal Rabbit Anti Thymocyte Globulin) Has In Vitro Activity in Multiple Myeloma.

Role of the Chemokine Receptor CXCR4 in Waldenstrom Macroglobulinemia.

Proteomic Analysis of Multiple Myeloma Identifies Potential Targets for Drug Therapy.

Proteomic Analysis of Targeted Therapeutic Agents in Multiple Myeloma (MM).

Proteomic Analysis of Waldenstrom Macroglobulinemia (WM) and IgM Monoclonal Gammopathy of Undetermined Significance (IgM-MGUS) Identifies Potential Targets for Drug Therapy.

Bone marrow angiogenic ability and expression of angiogenic cytokines in myeloma: evidence favoring loss of marrow angiogenesis inhibitory activity with disease progression

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only